Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-023569
Filing Date
2025-02-19
Accepted
2025-02-19 20:05:09
Documents
1
Period of Report
2025-02-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 11520
  Complete submission text file 0000950170-25-023569.txt   13025
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SERESTHERAPEUTICS, INC. 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
von Moltke Lisa (Reporting) CIK: 0001808592 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 25642772